PT Soho Global Health Tbk Officially Divests All Shares in Pfizer Indonesia
Published
PT Soho Global Health Tbk (SOHO) has just announced a strategic move in their business structure. The company has officially divested all of the shares they held in PT Pfizer Indonesia.
Based on official information, all of SOHO's shares in the pharmaceutical company have been transferred to the buyer, Pfizer Corporation Hong Kong Limited. This move marks the end of the shareholding partnership between SOHO and Pfizer Indonesia.
This decision is part of the company's internal policy regarding their investment portfolio. Despite divesting the shares, PT Soho Global Health Tbk continues to conduct other pharmaceutical business operations in the Indonesian market.
For healthcare industry players and investors, this change in ownership is a point of interest as Pfizer Indonesia is one of the major players in providing health products in the country. To date, there is no further information regarding the impact of this change on the availability of Pfizer products in the local market.
Overall, this transaction reflects the constantly evolving business dynamics in the Indonesian pharmaceutical sector. SOHO's management is expected to remain focused on developing their core business lines following the completion of the share divestment process.
Sources: KONTAN
More Indonesia news
- Huawei Watch D3 Launches in Indonesia on 19 November 2026
- Riau Islands Becomes Indonesia's Most Digitally Connected Province in 2025
- Indonesia's Digital Economy Potential Reaches USD 365 Billion, Government Strengthens AI Infrastructure
- Developing Chip Technology Requires the Support of Indonesia's Semiconductor Talent
- Giring Ganesha Leaves PSI, Party Says Political World Is Full of Change
- PT Rans Animasi Indonesia Wins Influencer Contract Worth Rp14.7 Billion from Two Ministries
- Indonesia Surrounded by Sea, But Port Investment Remains Limited
- Sanur SEZ Records 36,798 Patient Visits, Strengthens National Health Tourism